German Journal of Veterinary Research Current pharmacotherapeutic properties of low-dose naltrexone therapy in humans and possible therapeutic and prophylactic indications in cats and dogs
German Journal of Veterinary Research Current pharmacotherapeutic properties of low-dose naltrexone therapy in humans and possible therapeutic and prophylactic indications in cats and dogs Reza G Marangaloo et al., March 2024 German Journal of Veterinary Research 4(1):39-45 Naltrexone was first developed in 1963 as an opioid antagonist for therapeutic use in opioid-dependent individuals (alcohol, narcotics, and […]
Current pharmacotherapeutic properties of low-dose naltrexone therapy in humans and possible therapeutic and prophylactic indications in cats and dogs
Reza G. Marangaloo et al., German Journal of Veterinary Research, 20th February 2024 https://gmpc-akademie.de/articles/1709702482_2024_4_1_0070_GJVR_Marangaloo.pdf Abstract Naltrexone was first developed in 1963 as an opioid antagonist for therapeutic use in opioid-dependent individuals (alcohol, narcotics, and tobacco) with a 50 mg/day dose approved by the Food and Drug Administration (FDA). In 1985, Dr. Bernard Bihari explained that when […]
LDN Veterinarian 2026 Guide
Pets and Low Dose Naltrexone (LDN)
The LDN Book 3 (LDN; low dose naltrexone)
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
Dosing of Low Dose Naltrexone (LDN)
Sleep Issues and Low Dose Naltrexone (LDN)
Dosing of Low Dose Naltrexone (LDN) for Pets
The Immune System and Low Dose Naltrexone (LDN)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com